计算流体动力学作为冠状动脉疾病诊断和治疗的辅助技术:国际调查
Claudio Chiastra1, Marco Zuin2, Gianluca Rigatelli3
1PoliToBIOMed Lab, Department of Mechanical and Aerospace Engineering, Politecnico di Torino, Turin, Italy.
Frontiers in cardiovascular medicine
|September 18, 2023
概括
干预性心脏病学家对冠状动脉疾病 (CAD) 治疗的计算流体动力学 (CFD) 显著感兴趣. 他们热衷于采用CFD模拟和患者特定分析,以改善临床决策.
科学领域:
- 心血管医学 心血管医学
- 医疗技术 医疗技术 医学技术
- 计算科学 计算科学
背景情况:
- 计算流体动力学 (CFD) 是一种新兴技术,用于改善冠状动脉疾病 (CAD) 的程序结果和临床决策.
- 评估CFD在CAD诊断和治疗中的当前知识,利用和临床接受度至关重要.
研究的目的:
- 评估干预心脏病学家对计算流体动力学 (CFD) 的认识和理解,以评估其在冠状动脉疾病 (CAD) 中的应用.
- 评估基于CFD的分析在常规干预心脏病实践中的临床可接受性和潜在采用.
主要方法:
- 一个国际性的,匿名的,横截面调查,包括20个问题,被给予干预性心脏病学家.
- 数据收集发生在2022年5月18日至2022年6月12日,来自42个国家的466名心脏病专家的回复.
主要成果:
- 66.6%的受访者熟悉CFD,主要用于技术优化和CAD中的血液动力学评估.
- 大约30%的受访者对CFD衍生数量 (如壁切应力) 有准确的了解.
- 很高的百分比 (85.9%) 将考虑针对患者的CFD分析,87.7%的人对 Point-of-Care CFD软件感兴趣.
结论:
- 干预性心脏病学家对将CFD模拟纳入他们日常CAD治疗实践非常感兴趣.
- 对于CFD原则和临床应用的可访问软件解决方案的基础培训有明显的需求.
相关概念视频
01:27Coronary Artery Disease V: Interprofessional Care
9
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
9
01:28Imaging Studies for Cardiovascular System V: CT
41
Cardiac computed tomography (CT) scanning is an advanced cardiac imaging technique that utilizes CT technology, with or without intravenous (IV) contrast, to produce accurate cross-sectional virtual slices of specific areas of the heart, coronary circulation, and major blood vessels such as the aorta, pulmonary veins, and arteries. The computer processes these slices to generate three-dimensional images. Multidetector CT (MDCT) is a rapid form of CT scanning that captures multiple slices...
41
01:30Coronary Artery Disease I: Introduction
20
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
20
01:30Acute Coronary Syndrome III: Diagnostic Studies
9
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
9
01:26Coronary Artery Disease II: Pathophysiology
12
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
12
01:25Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
39
Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
39